What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
Koichi Akashi mostly deals with Immunology, Haematopoiesis, Myeloid, Progenitor cell and Stem cell.
His Immunology research includes themes of Phenotype, Megakaryocyte and Progenitor.
His Haematopoiesis research is multidisciplinary, incorporating elements of CD34, Cancer research, Myeloid leukemia and Transcription factor.
His research on Myeloid also deals with topics like
- Dendritic cell homeostasis which intersects with area such as Conventional Dendritic Cell,
- Adult stem cell that connect with fields like IRF8.
His Progenitor cell research includes elements of Hematopoietic stem cell and Gene, Cellular differentiation.
In his study, which falls under the umbrella issue of Stem cell, Neoplasm is strongly linked to Xenotransplantation.
His most cited work include:
- A clonogenic common myeloid progenitor that gives rise to all myeloid lineages (2167 citations)
- A clonogenic common myeloid progenitor that gives rise to all myeloid lineages (2167 citations)
- Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow (1919 citations)
What are the main themes of his work throughout his whole career to date?
Koichi Akashi spends much of his time researching Immunology, Internal medicine, Haematopoiesis, Stem cell and Cancer research.
The various areas that Koichi Akashi examines in his Immunology study include Transplantation, Graft-versus-host disease and Cytotoxic T cell.
His Haematopoiesis research is multidisciplinary, incorporating perspectives in Progenitor cell, Myeloid, CD34, Molecular biology and Bone marrow.
His Progenitor cell study introduces a deeper knowledge of Cell biology.
Koichi Akashi works in the field of Stem cell, focusing on Hematopoietic stem cell in particular.
His Cancer research study combines topics from a wide range of disciplines, such as Cancer stem cell, Cancer and Leukemia.
He most often published in these fields:
- Immunology (37.02%)
- Internal medicine (31.26%)
- Haematopoiesis (31.04%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (31.26%)
- Cancer research (21.33%)
- Oncology (9.48%)
In recent papers he was focusing on the following fields of study:
Koichi Akashi mainly focuses on Internal medicine, Cancer research, Oncology, Gastroenterology and Immunology.
His study looks at the intersection of Internal medicine and topics like Cardiology with Cardiotoxicity.
His studies deal with areas such as Cancer stem cell, Cancer, Stem cell and Leukemia as well as Cancer research.
His Stem cell study focuses on Haematopoiesis in particular.
His research links Progenitor cell with Haematopoiesis.
His study in Gastroenterology is interdisciplinary in nature, drawing from both Prospective cohort study, Adverse effect and Tacrolimus.
Between 2017 and 2021, his most popular works were:
- Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial (84 citations)
- Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets (69 citations)
- Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS (48 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Koichi Akashi mainly investigates Internal medicine, Cancer research, Gastroenterology, Stem cell and Immunology.
In his research, Myelogenous, Leukemia, Discontinuation, Nilotinib and Sokal Score is intimately related to Oncology, which falls under the overarching field of Internal medicine.
His research in Cancer research intersects with topics in Cancer, Colorectal cancer and T cell, CD8, Immune system.
His research in Stem cell is mostly concerned with Haematopoiesis.
His Haematopoiesis research integrates issues from Aplastic anemia, Bone marrow, Cytotoxic T cell and Progenitor cell.
All of his Immunology and Serum samples and Myeloid investigations are sub-components of the entire Immunology study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
